In a randomized controlled trial, 87 pregnant women with GDM or type 2 diabetes mellitus (T2DM) received insulin detemir (n=42) or NPH (n=45), with short-acting insulin aspart as needed. The gene discussed is INS; the disease is gestational diabetes.